Ameritas Investment Partners, Inc. - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 53 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q1 2019$3,000
+50.0%
1,8150.0%0.00%
Q4 2018$2,000
-81.8%
1,8150.0%0.00%
-100.0%
Q3 2018$11,000
-42.1%
1,8150.0%0.00%0.0%
Q2 2018$19,0000.0%1,8150.0%0.00%0.0%
Q1 2018$19,000
+46.2%
1,8150.0%0.00%0.0%
Q4 2017$13,000
+8.3%
1,8150.0%0.00%0.0%
Q3 2017$12,000
-29.4%
1,8150.0%0.00%0.0%
Q2 2017$17,000
+240.0%
1,815
+214.0%
0.00%
Q1 2017$5,0005780.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2017
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders